InvestorsHub Logo
Post# of 4973165
Next 10
Followers 5
Posts 2568
Boards Moderated 0
Alias Born 11/03/2019

Re: None

Wednesday, 06/01/2022 10:10:36 AM

Wednesday, June 01, 2022 10:10:36 AM

Post# of 4973165
$ATRX Adhera Therapeutics has recently licensed two drug candidates, MLR-1019 and MLR-1023, from the Melior Discovery family of companies. $GILD KU Leuven, Gilead Sciences enter licence agreement to develop antivirals.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.